Key facts
- This page summarizes Grant Froese's Form 3 filing for Helus Pharma Inc. (HELP).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Oct 2026, 19:19.
Grant Froese - 13 Oct 2026 Form 3 Insider Report for Helus Pharma Inc. (HELP)
- Reporting relationship
- Director
- Issuer ticker
- HELP
- Reported as of
- 13 Oct 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Grant Froese
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Grant Froese filed Form 3 for Helus Pharma Inc. (HELP) on 23 Oct 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002113261
Primary reporting owner
Froese Grant
- Relationship
- Director
- Address
- C/O HELUS PHARMA INC., 100 KING STREET W., SUITE 5600, TORONTO, ONTARIO, CANADA
- Signature
- /s/ Grant Froese
- Signature date
- 23 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HELP
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,263
- Date
- 13 Oct 2026
- Ownership
- Held by spouse
HELP
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 156,000
- Date
- 13 Oct 2026
- Ownership
- Held by Greywolf Management Services Inc.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HELP
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 19,737
- Exercise price
- $17.37
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Held by Greywolf Management Services Inc., a corporation owned and controlled by the reporting person.
Footnote F2
Converted from Canadian exercise price of C$24.32 using an exchange rate of C$1.4 = US$1.00.